CG Life Appoints Brian Caracciolo as CFO to Support Next Phase of Growth and Agency Expansion

CHICAGO & NEW YORK & SAN DIEGO--(BUSINESS WIRE)--CG Life, a specialized pharma agency built for the unique challenges of bringing therapies for rare and hard-to-treat diseases to market, has appointed Brian Caracciolo as the agency’s Chief Financial Officer (CFO). With more than 25 years of financial management experience, Caracciolo joins CG Life at a time of strong growth for the firm and will lead the company’s financial strategy, operational discipline, and readiness as a scaled, private equity-backed agency.

“As CG Life grows, our focus tightens, and the business needs to become more transparent and predictable,” said David Ormesher, CEO of CG Life. “Brian has spent his career building financial infrastructure inside complex, fast-scaling organizations. He brings the discipline and clarity we need to support growth, integrate future acquisitions, and operate with greater business confidence. With Brian on board, we will continue to see positive expansion on our impact for biopharma clients and deliver on our long-term ambitions as we move into our next chapter.”

Most recently, Caracciolo served as CFO of Earned, a provider of comprehensive tax and wealth solutions for healthcare professionals. Prior to that, he was CFO for Alera Group, where he helped scale a national platform through rapid acquisition and integration. Earlier in his career, he held senior finance leadership roles at Baxter International, Hub International, and PwC.

“CG Life has built real momentum on a strong foundation,” said Caracciolo. “What drew me to the agency is the opportunity to bring more clarity to how the business operates as it scales — improving visibility, supporting better decision-making, and ensuring the business is investing in the right areas to sustain growth over time. I am excited to join the mission to achieve extraordinary impact for our people and our clients.”

CG Life has grown substantially in recent years by building deeper AOR partnerships with clients in rare disease and precision medicine. To support its growth strategy, the agency has also made key acquisitions to add greater scale and new capabilities for launch support and engagements spanning everything from scientific storytelling to omnichannel activation.

About CG Life

Founded in 2003, CG Life is a specialized pharma agency built for the unique challenges of bringing therapies for rare and hard-to-treat diseases to market, where traditional commercialization models often fall short. CG Life partners with biopharma companies to navigate the complexity of rare disease commercial launches by combining deep scientific expertise, strategy-led activation of physician and patient communities, and results-driven engagement to support what's best for patients. The result is faster, more effective launches in markets where insight, creativity, and credibility determine success.

Begin your journey at CGLife.com.